BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7761407)

  • 21. Impact of cAMP on the T-cell response to type II collagen.
    Ozegbe P; Foey AD; Ahmed S; Williams RO
    Immunology; 2004 Jan; 111(1):35-40. PubMed ID: 14678197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous IL-22 plays a dual role in arthritis: regulation of established arthritis via IFN-γ responses.
    Justa S; Zhou X; Sarkar S
    PLoS One; 2014; 9(3):e93279. PubMed ID: 24676270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4.
    Yoshino S; Murata Y; Ohsawa M
    J Immunol; 1998 Dec; 161(12):6904-8. PubMed ID: 9862723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gallium nitrate ameliorates type II collagen-induced arthritis in mice.
    Choi JH; Lee JH; Roh KH; Seo SK; Choi IW; Park SG; Lim JG; Lee WJ; Kim MH; Cho KR; Kim YJ
    Int Immunopharmacol; 2014 May; 20(1):269-75. PubMed ID: 24656780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to mercuric chloride during the induction phase and after the onset of collagen-induced arthritis enhances immune/autoimmune responses and exacerbates the disease in DBA/1 mice.
    Hansson M; Djerbi M; Rabbani H; Mellstedt H; Gharibdoost F; Hassan M; Depierre JW; Abedi-Valugerdi M
    Immunology; 2005 Mar; 114(3):428-37. PubMed ID: 15720444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type II collagen-induced murine arthritis. II. Genetic control of arthritis induction is expressed on L3T4+ T cells required for humoral as well as cell-mediated immune responses to type II collagen.
    Seki N; Sudo Y; Yamane A; Sugihara S; Takai Y; Ishihara K; Ono S; Hamaoka T; Senoh H; Fujiwara H
    Reg Immunol; 1989; 2(4):203-12. PubMed ID: 2577123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amelioration of collagen-induced arthritis and suppression of interferon-gamma, interleukin-12, and tumor necrosis factor alpha production by interferon-beta gene therapy.
    Triantaphyllopoulos KA; Williams RO; Tailor H; Chernajovsky Y
    Arthritis Rheum; 1999 Jan; 42(1):90-9. PubMed ID: 9920019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial lipopolysaccharide acts as an adjuvant to induce autoimmune arthritis in mice.
    Yoshino S; Sasatomi E; Ohsawa M
    Immunology; 2000 Apr; 99(4):607-14. PubMed ID: 10792509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Schols D; De Wolf-Peeters C; Billiau A
    J Immunol; 1999 Sep; 163(6):3503-10. PubMed ID: 10477624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of collagen-induced arthritis in mice by diesel exhaust particles.
    Yoshino S; Sagai M
    J Pharmacol Exp Ther; 1999 Aug; 290(2):524-9. PubMed ID: 10411558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses.
    Veenbergen S; Smeets RL; Bennink MB; Arntz OJ; Joosten LA; van den Berg WB; van de Loo FA
    Ann Rheum Dis; 2010 Jan; 69(1):276-83. PubMed ID: 19188194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice.
    Matthys P; Vermeire K; Mitera T; Heremans H; Huang S; Billiau A
    Eur J Immunol; 1998 Jul; 28(7):2143-51. PubMed ID: 9692883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis.
    Palmer G; Talabot-Ayer D; Lamacchia C; Toy D; Seemayer CA; Viatte S; Finckh A; Smith DE; Gabay C
    Arthritis Rheum; 2009 Mar; 60(3):738-49. PubMed ID: 19248109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production.
    Lo CK; Lam QL; Sun L; Wang S; Ko KH; Xu H; Wu CY; Zheng BJ; Lu L
    Arthritis Rheum; 2008 Sep; 58(9):2700-11. PubMed ID: 18759269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC; Michaëlsson E; Brunmark C; Andersson M
    J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses.
    Hsiao HB; Hsieh CC; Wu JB; Lin H; Lin WC
    BMC Complement Altern Med; 2016 Feb; 16():80. PubMed ID: 26916550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
    Strid J; Tan LA; Strobel S; Londei M; Callard R
    PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA).
    Marinova-Mutafchieva L; Williams RO; Mason LJ; Mauri C; Feldmann M; Maini RN
    Clin Exp Immunol; 1997 Mar; 107(3):507-12. PubMed ID: 9067525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant composition determines the induction of type II collagen-induced arthritis.
    Ellis JS; Chain BM; Cooke A; Ibrahim MA; Katz DR
    Scand J Immunol; 1992 Jul; 36(1):49-56. PubMed ID: 1615283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.